Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sebastien Deleuze
The PPAR Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Related publications
Apoptosis Rate and Transcriptional Response of Pancreatic Islets Exposed to the PPAR Gamma Agonist Pioglitazone
Diabetology and Metabolic Syndrome
Internal Medicine
Endocrinology
Metabolism
Diabetes
PPAR-γ Agonist Protects Against Intestinal Injury During Necrotizing Enterocolitis
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Pioglitazone, a PPAR Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Inhibiting Nonmuscle Myosin II Impedes Inflammatory Infiltration and Ameliorates Progressive Renal Disease
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Endogenous Urokinase Lacks Antifibrotic Activity During Progressive Renal Injury
American Journal of Physiology - Renal Physiology
Urology
Physiology
Inhibition of Thromboxane Synthesis Ameliorates the Progressive Kidney Disease of Rats With Subtotal Renal Ablation.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A Specific Peroxisome Proliferator-Activated Receptor-Γ (PPAR-γ) Ligand, Pioglitazone, Ameliorates Gastric Mucosal Damage Induced by Ischemia and Reperfusion in Rats
Redox Report
Biochemistry
Clinical Biochemistry
Cell Biology
Physiology
Synergistic Antinociception by the Cannabinoid Receptor Agonist Anandamide and the PPAR-α Receptor Agonist GW7647
European Journal of Pharmacology
Pharmacology
Blockade of the Renin-Angiotensin and Endothelin Systems on Progressive Renal Injury
Hypertension
Internal Medicine
